DEPRES II (Depression Research in European Society II): A patient survey of the symptoms, disability and current management of depression in the community

International Clinical Psychopharmacology

Volumn 14, Issue 3, 1999, Pages 139-151

  Tylee, A ^a   Gastpar, M ^a   Lepine J P ^a   Mendlewicz, J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Community; Depression; Disability; Healthcare utilization; Management

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BODY WEIGHT DISORDER; COMMUNITY CARE; CONCENTRATION LOSS; DAILY LIFE ACTIVITY; DEPRESSION; EMPLOYMENT; FATIGUE; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; MOOD; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP DISORDER; SYMPTOM;

EID: 0032796231     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199905002-00001     Document Type: Article

References (28)

1. Agency for Health Care Policy and Research (1993) Depression in Primary Care. Clinical practice guideline, number 5. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR publication no. 93-0550.
2. Angst J (1997) A regular review of the long term follow up of depression. Br Med J 315:1146-1146.
3. Ashton H (1994) Guidelines for the rational use of benzodiazepines. When and what to use. Drugs 48:25-40.
4. Boyer WF, Feighner JP (1991a) The efficacy of selective serotonin reuptake inhibitors in depression. In: Perspectives in Psychiatry: Selective Serotonin Reuptake Inhibitors, vol. 1 (Feighner JP, Boyer WF, eds), Chichester: Wiley, pp. 89-108; 133-152.
5. Broadhead WE, Blazer DG, George LK, Tse CK (1990) Depression, disability days, and days lost from work in a prospective epidemiological survey. JAMA 264:2524-2528.
6. Donoghue J, Tylee A (1996) The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 168:164-168.
7. Howarth E, Johnson J, Klerman GL, Weissman MM (1992) Depressive symptoms as relative and attributable risk factors for first-onset major depression. Arch Gen Psychiatry 49:817-823.
8. Johnson J, Weissman MM, Klerman GL (1992) Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 267:1478-1483.
9. Kasper S, Lépine JP, Mendlewicz J, Montgomery SA, Rush JA Jr (1995) Efficacy, safety, and indications for tricyclic and newer antidepressants. Depression 2:127-137.
10. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, et al. (1995) Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 273:1026-1031.
11. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
12. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz LJ, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry 30:17-30.
13. Kessler RC, Zhao S, Blazer DG, Swartz M (1997) Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 45:19-30.
14. Lader M, Russell J (1993) Guidelines for the prevention and treatment of benzodiazepine dependence: summary of a report from the Mental Health Foundation. Addiction 88:1707-1708.
15. Lecrubier Y, Üstün TB (1998) Panic and depression: a worldwide primary care perspective. Int Clin Psychopharmacol 13 (Suppl. 4):S7-S11.
16. Lenox RH, Shipley JE, Peyser JM (1984) Double-blind comparison of alprazolam vs. imipramine in panic disorder. Psychopharmacol Bull 20:79-82.
17. Lépine J-P, Gastpar M, Mendlewicz, Tylee A, on behalf of the DEPRES Steering Committee (1997) Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 12:19-29.
18. Olfson M, Klerman GL (1992) The treatment of depression: prescribing practices of primary care physicians and psychiatrists. J Fam Pract 35:627-635.
19. Ormel J, VonKorff M, Üstün TB, Pini S, Korten A, Oldehinkel T (1994) Common mental disorders and disability across cultures. JAMA 272:1741-1748.
20. Paykel ES, Priest RG (1992) Recognition and management of depression in general practice: consensus statement. Br Med J 305:1198-1202.
21. Sheehan DV, Lecrubier Y, Janavs J, Knapp E, Weiller E, Bonora LI, et al. (1994) Mini International Neuropsychiatric Interview (MINI). University of South Florida Institute for Research in Psychiatry, Tampa, FL and INSERM-Hôpital de la Salpêtrière, Paris, France.
22. Sherbourne CD, Jackson CA, Meredith LS, Camp MA, Wells B (1996) Prevalence of comorbid anxiety disorders in primary care outpatients. Arch Fam Med 5:27-34.
23. Tylee A (1996) The secondary presentation of depression. In: The Prevention of Mental Illness in Primary Care (Kendrick T, Tylee A, Freeling P), Cambridge: Cambridge University Press.
24. Üstün TB, Sartorius N (1995) Mental Illness in General Health Care. An International Study. Chichester: Wiley.
25. Üstün TB, Goldberg D, Cooper J, Simon GE, Sartorius N (1995) New classification for mental disorders with management guidelines for use in primary care: ICD-10 PHC chapter five. Br J Gen Pract 45:211-215.
26. VonKorff M, Ormel J, Katon W, Lin EHB (1992) Disability and depression among high utilizers of health care: a longitudinal analysis. Arch Gen Psychiatry 49:91-100.
27. Wells KB, Rogers W, Burnam A, Greenfield S, Ware JE Jr (1991) How the medical comorbidity of depressed patients differs across health care settings: results from the Medical Outcomes Study. Am J Psychiatry 148:1688-1696.
28. Wohlfarth TD, Van den Brink W, Ormel J, Koeter MWJ, Oldehinkel AJ (1993) The relationship between social dysfunctioning and psychopathology. Br J Psychiatry 163:37-44.